Mixed Dyslipidemia Among Patients Using Lipid-Lowering Therapy in French General Practice: An Observational Study
Authors:
- Eric Van GanseEGEric Van Ganse
- Laurent LaforestLLLaurent Laforest
- Thomas BurkeTBThomas Burke
- Hemant PhatakHPHemant Phatak
- Thierry SouchetTSThierry Souchet
- 1 August 2007
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 29 (8) , 1671-1681
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Trends in Serum Lipids and Lipoproteins of Adults, 1960-2002JAMA, 2005
- Recent National Cholesterol Education Program Adult Treatment Panel III Update: Adjustments and OptionsThe American Journal of Cardiology, 2005
- Ineffectiveness of lipid‐lowering therapy in primary careBritish Journal of Clinical Pharmacology, 2005
- The Association Between Lipid Levels and the Risks of Incident Myocardial Infarction, Stroke, and Total Mortality: The Cardiovascular Health StudyJournal of the American Geriatrics Society, 2004
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatmentEuropean Heart Journal, 2001
- Relation of High TG–Low HDL Cholesterol and LDL Cholesterol to the Incidence of Ischemic Heart DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarctionJAMA, 1996
- Serum triglycerides in the prediction of coronary artery disease (an Italian experience)The American Journal of Cardiology, 1994
- Plasma Triglyceride Level and Mortality from Coronary Heart DiseaseNew England Journal of Medicine, 1993